Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Adamantinoma and osteofibrous dysplasia: management options

Springfield, Dempsey

Current Opinion in Orthopaedics: December 2004 - Volume 15 - Issue 6 - pp 452-455
Tumors
Buy

Purpose of review: Although osteofibrous dysplasia and adamantinoma are rare tumors, they occur in sufficient numbers to be encountered by most orthopaedic surgeons. They have similar presentations and are probably histopathologically related. Osteofibrous dysplasia is usually best observed and not operated on, but adamantinoma is a malignancy and should be widely excised.

Recent findings: Recent evaluations have continued to confirm that osteofibrous dysplasia and fibrous dysplasia are distinct, unrelated conditions. Osteofibrous dysplasia is now recognized to be associated with adamantinoma, and there is growing evidence that they are closely related entities.

Summary: Osteofibrous dysplasia and adamantinoma are similar and related but are treated much differently. The clinician needs to know how to distinguish between them.

Leni & Peter W. May Department of Orthopaedics, Mount Sinai Medical Center, New York, New York, USA

Correspondence to Dempsey Springfield, Leni & Peter W. May Department of Orthopaedics, Mount Sinai Medical Center, 5 East 98 Street, Box 1188, New York, New York, USA

Tel: ; fax: ; e-mail: Dempsey.Springfield@msnyuhealth.org

© 2004 Lippincott Williams & Wilkins, Inc.